Tumour-infiltrating lymphocytes in cancer: Implications for the diagnostic pathologist

Diagnostic Histopathology

Volumn 17, Issue 2, 2011, Pages 80-90

  Simonson, William T N ^a   Allison, Kimberly H ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Cancer; Immune response; Inflammation; Prognosis; Tumour infiltrating lymphocytes, TILs

Indexed keywords

ANUS CARCINOMA; ARTICLE; BREAST CARCINOMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLORECTAL CARCINOMA; ENDOMETRIUM CARCINOMA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; KIDNEY CARCINOMA; LARGE CELL LYMPHOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MELANOMA; MERKEL CELL TUMOR; NASOPHARYNX CARCINOMA; NATURAL KILLER CELL; OVARY CARCINOMA; PANCREAS ADENOCARCINOMA; PLEURA MESOTHELIOMA; PROSTATE CARCINOMA; RECTUM CARCINOMA; REGULATORY T LYMPHOCYTE; T CELL LYMPHOMA; TRANSITIONAL CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE;

EID: 79951683399     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2010.10.006     Document Type: Article

References (93)

1. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899. PMCID: PMC2866629.
2. Burnet F.M. The concept of immunological surveillance. Prog Exp Tumor Res 1970, 13:1-27.
3. Thomas L. On immunosurveillance in human cancer. Yale J Biol Med 1982, 55:329-333. PMCID: PMC2596448.
4. Shankaran V., Ikeda H., Bruce A.T., et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410:1107-1111.
5. Swann J.B., Smyth M.J. Immune surveillance of tumors. J Clin Invest 2007, 117:1137-1146. PMCID: PMC1857231.
6. Starnes C.O. Coley's toxins in perspective. Nature 1992, 357:11-12.
7. Coley W.B. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res 1991, 262:3-11.
8. Dalbagni G. The management of superficial bladder cancer. Nat Clin Pract Urol 2007, 4:254-260.
9. Clemente C.G., Mihm M.C., Bufalino R., Zurrida S., Collini P., Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996, 77:1303-1310.
10. Clark W.H., Elder D.E., Guerry Dt, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989, 81:1893-1904.
11. Elder D.E., Guerry Dt, VanHorn M., et al. The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm). Cancer 1985, 56:413-418.
12. House A.K., Watt A.G. Survival and the immune response in patients with carcinoma of the colorectum. Gut 1979, 20:868-874. PMCID: PMC1412722.
13. Jass J.R. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 1986, 39:585-589. PMCID: PMC499954.
14. Ropponen K.M., Eskelinen M.J., Lipponen P.K., Alhava E., Kosma V.M. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997, 182:318-324.
15. Zhang L., Conejo-Garcia J.R., Katsaros D., et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003, 348:203-213.
16. Marrogi A.J., Munshi A., Merogi A.J., et al. Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer 1997, 74:492-501.
17. Petersen R.P., Campa M.J., Sperlazza J., et al. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 2006, 107:2866-2872.
18. Vesalainen S., Lipponen P., Talja M., Syrjanen K. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994, 30A:1797-1803.
19. Barnhill R.L., Fine J.A., Roush G.C., Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 1996, 78:427-432.
20. Taylor R.C., Patel A., Panageas K.S., Busam K.J., Brady M.S. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 2007, 25:869-875.
21. Grabenbauer G.G., Lahmer G., Distel L., Niedobitek G. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res 2006, 12(11 Pt 1):3355-3360.
22. Oudejans J.J., Jiwa N.M., Kummer J.A., et al. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. Blood 1997, 89:1376-1382.
23. Aaltomaa S., Lipponen P., Eskelinen M., et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 1992, 28A:859-864.
24. Rakha E.A., Aleskandarany M., El-Sayed M.E., et al. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer 2009, 45:1780-1787.
25. Ogino S., Nosho K., Irahara N., et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009, 15:6412-6420. PMCID: PMC2771425.
26. Naito Y., Saito K., Shiiba K., et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998, 58:3491-3494.
27. Salama P., Phillips M., Grieu F., et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009, 27:186-192.
28. Prall F., Duhrkop T., Weirich V., et al. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol 2004, 35:808-816.
29. Pages F., Berger A., Camus M., et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005, 353:2654-2666.
30. Sinicrope F.A., Rego R.L., Ansell S.M., Knutson K.L., Foster N.R., Sargent D.J. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma. Gastroenterology 2009, 137:1270-1279. PMCID: PMC2873775.
31. Coca S., Perez-Piqueras J., Martinez D., et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997, 79:2320-2328.
32. Frey D.M., Droeser R.A., Viehl C.T., et al. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 2010, 126:2635-2643.
33. Tzankov A., Meier C., Hirschmann P., Went P., Pileri S.A., Dirnhofer S. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 2008, 93:193-200.
34. Kondratiev S., Sabo E., Yakirevich E., Lavie O., Resnick M.B. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 2004, 10:4450-4456.
35. de Jong R.A., Leffers N., Boezen H.M., et al. Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer. Gynecol Oncol 2009, 114:105-110.
36. Zingg U., Montani M., Frey D.M., et al. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus. Eur J Surg Oncol 2010, 36:670-677.
37. Cho Y., Miyamoto M., Kato K., et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 2003, 63:1555-1559.
38. Schumacher K., Haensch W., Roefzaad C., Schlag P.M. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 2001, 61:3932-3936.
39. Carreras J., Lopez-Guillermo A., Fox B.C., et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006, 108:2957-2964.
40. Songun I., van de Velde C.J., Hermans J., et al. Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG). Br J Cancer 1996, 74:1783-1788. PMCID: PMC2077204.
41. Badoual C., Hans S., Rodriguez J., et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006, 12:465-472.
42. Gao Q., Qiu S.J., Fan J., et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007, 25:2586-2593.
43. Sasaki A., Tanaka F., Mimori K., et al. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma. Eur J Surg Oncol 2008, 34:173-179.
44. Kobayashi N., Hiraoka N., Yamagami W., et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007, 13:902-911.
45. Alvaro T., Lejeune M., Salvado M.T., et al. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005, 11:1467-1473.
46. ten Berge R.L., Oudejans J.J., Dukers D.F., Meijer J.W., Ossenkoppele G.J., Meijer C.J. Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker. Leukemia 2001, 15:458-464.
47. Villegas F.R., Coca S., Villarrubia V.G., et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer 2002, 35:23-28.
48. Anraku M., Cunningham K.S., Yun Z., et al. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2008, 135:823-829.
49. Paulson K, Iyer J, Tegeder A, et al. Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol, in press.
50. Andea A.A., Coit D.G., Amin B., Busam K.J. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008, 113:2549-2558.
51. Mott R.T., Smoller B.R., Morgan M.B. Merkel cell carcinoma: a clinicopathologic study with prognostic implications. J Cutan Pathol 2004, 31:217-223.
52. Llombart B., Monteagudo C., Lopez-Guerrero J.A., et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology 2005, 46:622-634.
53. Zhang Y.L., Li J., Mo H.Y., et al. Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. Mol Cancer 2010, 9:4. PMCID: PMC2818695.
54. Kawai O., Ishii G., Kubota K., et al. Predominant infiltration of macrophages and CD8(+) T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 2008, 113:1387-1395.
55. Sato E., Olson S.H., Ahn J., et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 2005, 102:18538-18543. PMCID: PMC1311741.
56. Clarke B., Tinker A.V., Lee C.H., et al. Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss. Mod Pathol 2009, 22:393-402.
57. Curiel T.J., Coukos G., Zou L., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004, 10:942-949.
58. Tomsova M., Melichar B., Sedlakova I., Steiner I. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol 2008, 108:415-420.
59. Leffers N., Gooden M.J., de Jong R.A., et al. Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol Immunother 2009, 58:449-459.
60. Shah C.A., Allison K.H., Garcia R.L., Gray H.J., Goff B.A., Swisher E.M. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol 2008, 109:215-219.
61. Hamanishi J., Mandai M., Iwasaki M., et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci USA 2007, 104:3360-3365. PMCID: PMC1805580.
62. Stumpf M., Hasenburg A., Riener M.O., et al. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. Br J Cancer 2009, 101:1513-1521. PMCID: PMC2778517.
63. Hiraoka N., Onozato K., Kosuge T., Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006, 12:5423-5434.
64. Fukunaga A., Miyamoto M., Cho Y., et al. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 2004, 28:e26-e31.
65. Nakano O., Sato M., Naito Y., et al. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001, 61:5132-5136.
66. Siddiqui S.A., Frigola X., Bonne-Annee S., et al. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 2007, 13:2075-2081.
67. Sharma P., Shen Y., Wen S., et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci USA 2007, 104:3967-3972. PMCID: PMC1820692.
68. Dolcetti R., Viel A., Doglioni C., et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 1999, 154:1805-1813. PMCID: PMC1866613.
69. Guidoboni M., Gafa R., Viel A., et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 2001, 159:297-304. PMCID: PMC1850401.
70. Michael-Robinson J.M., Biemer-Huttmann A., Purdie D.M., et al. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 2001, 48:360-366. PMCID: PMC1760146.
71. Moore O.S., Foote F.W. The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 1949, 2:635-642.
72. Jacquemier J., Padovani L., Rabayrol L., et al. Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J Pathol 2005, 207:260-268.
73. Stoppa-Lyonnet D., Ansquer Y., Dreyfus H., et al. Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol 2000, 18:4053-4059.
74. Gaffey M.J., Mills S.E., Frierson H.F., et al. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. Mod Pathol 1995, 8:31-38.
75. Rubens J.R., Lewandrowski K.B., Kopans D.B., Koerner F.C., Hall D.A., McCarthy K.A. Medullary carcinoma of the breast. Overdiagnosis of a prognostically favorable neoplasm. Arch Surg 1990, 125:601-604.
76. Chin Y., Janseens J., Vandepitte J., Vandenbrande J., Opdebeek L., Raus J. Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 1992, 12:1463-1466.
77. Kohrt H.E., Nouri N., Nowels K., Johnson D., Holmes S., Lee P.P. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2005, 2. e284. PMCID: PMC1198041.
78. Bromwich E.J., McArdle P.A., Canna K., et al. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer 2003, 89:1906-1908. PMCID: PMC2394435.
79. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
80. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
81. Kondo T., Nakazawa H., Ito F., et al. Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response. Cancer Sci 2006, 97:780-786.
82. Kusuda T., Shigemasa K., Arihiro K., Fujii T., Nagai N., Ohama K. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer. Oncol Rep 2005, 13:1153-1158.
83. Galon J., Costes A., Sanchez-Cabo F., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313:1960-1964.
84. Bohling S.D., Allison K.H. Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target. Mod Pathol 2008, 21:1527-1532.
85. Fu J., Xu D., Liu Z., et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007, 132:2328-2339.
86. Wolf D., Wolf A.M., Rumpold H., et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 2005, 11:8326-8331.
87. Mahmoud SM, Paish EC, Powe DG, et al. An evaluation of the clinical significance of FOXP3(+) infiltrating cells in human breast cancer. Breast Cancer Res Treat.
88. Haas M., Dimmler A., Hohenberger W., Grabenbauer G.G., Niedobitek G., Distel L.V. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol 2009, 9:65. PMCID: PMC2749861.
89. Akbar A.N., Vukmanovic-Stejic M., Taams L.S., Macallan D.C. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat Rev Immunol 2007, 7:231-237.
90. Hinz S., Pagerols-Raluy L., Oberg H.H., et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 2007, 67:8344-8350.
91. Ebert L.M., Tan B.S., Browning J., et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells. Cancer Res 2008, 68:3001-3009.
92. Ishigami S., Natsugoe S., Tokuda K., et al. Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett 2000, 159:103-108.
93. Baehner F., Quale C., Pomeroy C., Cherbavaz C., Shak S. Biopsy cavities in breast cancer specimens: impact on quantitative RT-PTR gene expression profiles and recurrence risk assessment. Modern Pathol 2009, 22(suppl 1):28A-29A.